Fundraising Fox

Geoffrey Smith

Investor

Managing Partner at Digitalis Ventures

New York, New York

Writes $100K – $10M checks Β· typically $1.5M

FoundedGro Biosciences

About

Geoffrey W. Smith combines biotech leadership as Alcea Therapeutics CEO with training physicians and scientists at Columbia, chairs Central European University, and founded Digitalis Commons for public-minded health innovation.

Invests in

AI & Machine LearningBiotechDeep TechDigital HealthHardwareHealthtechMedical Devices

Experience

  1. Digitalis VenturesFounder/Managing Partnercurrent2016 β€” presentNew York City Metropolitan Area
  2. Digitalis CommonsFounder/Chairmancurrent2019 β€” present
  3. Digitalis LabsFounder/Director of Researchcurrent2025 β€” presentNew York, New York, United States
  4. Partnership Fund for New York CityDirectorcurrent2026 β€” presentNew York, New York, United States
  5. Salzburg Global SeminarDirectorcurrent2024 β€” present
  6. The Jackson LaboratoryTrusteecurrent2017 β€” present
  7. Icahn School of Medicine at Mount SinaiDirector, Mount Sinai Institute of Technology2013 β€” 2014New York, NY
  8. Icahn School of Medicine at Mount SinaiProfessor, Population Health Science and Policy2012 β€” 2014New York, NY
  9. The Rockefeller UniversityVisiting Scholar2006 β€” 2014New York, New York, United States

Education

  1. University of PennsylvaniaDoctor of Law (J.D.)
  2. Williams CollegeBachelor of Arts (B.A.)

Skills & more

Lifesciences27Biotechnology38Drug Discovery18Clinical Trials13Venture Capital51Management15Oncology4Infectious Diseases4Entrepreneurship12Technology Transfer7Pharmaceutical Industry4Cancer4
+9 moreCommercializationClinical DevelopmentCell BiologyGeneticsCell CultureLife SciencesStrategyStart-upsBusiness Strategy

From Geoffrey's professional profile.

Same school

Shared employers

Colleagues at Digitalis Ventures

Network8

Investors connected to Geoffrey in public investor directories β€” a warm-intro map.